Painful Papules on the Arms
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Skin and Breast Disease in the Differential Diagnosis of Chest Pain
Skin and breast disease in the differential diagnosis of chest pain Author Muir, Jim, Yelland, Michael Published 2010 Journal Title Medical Clinics of North America DOI https://doi.org/10.1016/j.mcna.2010.01.006 Copyright Statement © 2010 Elsevier. This is the author-manuscript version of this paper. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version. Downloaded from http://hdl.handle.net/10072/33712 Griffith Research Online https://research-repository.griffith.edu.au ARTICLE IN PRESS 1 2 Skin and Breast 3 4 Disease in the 5 6 Differential 7 8 Diagnosis of 9 10 Chest Pain 11 12 a, b ½Q2½ Q3 Jim Muir *, Michael Yelland ½Q4½ Q5 KEYWORDS 13 14 Chest pain Skin diseases Herpes zoster PROOF 15 Breast Neoplasm 16 17 18 Pain is not a symptom commonly associated with skin disease. This is especially so 19 when considering the known skin problems that have a presenting symptom of chest 20 pain that could potentially be confused with chest pain from other causes. 21 22 PAINFUL SKIN CONDITIONS 23 24 Several extremely painful and tender skin conditions present with dramatic clinical 25 signs. Inflammatory disorders such as pyoderma gangrenosum, skin malignancies, 26 both primary and secondary, acute bacterial infections such as erysipelas or cellulitis, 27 and multiple other infections are commonly extremely painful and tender. As these 28 conditions manifest with obvious skin signs such as swelling, erythema, localized 29 tenderness, fever, lymphangitis, and lymphadenopathy, there is little chance of misdi- 30 agnosis of symptoms as caused by anything other than a cutaneous pathology. -
Immunohistochemical Analysis of S100-Positive Epidermal
An Bras Dermatol. 2020;95(5):627---630 Anais Brasileiros de Dermatologia www.anaisdedermatologia.org.br DERMATOPATHOLOGY Immunohistochemical analysis of S100-positive ଝ,ଝଝ epidermal Langerhans cells in dermatofibroma Mahmoud Rezk Abdelwhaed Hussein Department of Pathology, Assuit University Hospital, Assuit, Egypt Received 3 February 2020; accepted 12 April 2020 Available online 12 July 2020 Abstract Dermatofibroma is a dermal fibrohistiocytic neoplasm. The Langerhans cells are the KEYWORDS immunocompetent cells of the epidermis, and they represent the first defense barrier of the Histiocytoma, benign immune system towards the environment. The objective was to immunohistologically compare fibrous; the densities of S100-positive Langerhans cells in the healthy peritumoral epidermis against Skin neoplasms; those in the epidermis overlying dermatofibroma (20 cases), using antibodies against the S100 S100 Proteins molecule (the immunophenotypic hallmark of Langerhans cells). The control group (normal, healthy skin) included ten healthy age and sex-matched individuals who underwent skin biopsies for benign skin lesions. A significantly high density of Langerhans cells was observed both in the epidermis of the healthy skin (6.00 ± 0.29) and the peritumoral epidermis (6.44 ± 0.41) vs. those in the epidermis overlying the tumor (1.44 ± 0.33, p < 0.05). The quantitative deficit of Langerhans cells in the epidermis overlying dermatofibroma may be a possible factor in its development. © 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier Espana,˜ S.L.U. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). Langerhans cells (LCs) are the exclusive antigen-presenting tions stained with hematoxylin and eosin as ‘‘clear cells’’ cells of the normal human epidermis. -
Storiform Collagenoma: Case Report Colagenoma Estoriforme: Relato De Caso
CASE REPORT Storiform collagenoma: case report Colagenoma estoriforme: relato de caso Guilherme Flosi Stocchero1 ABSTRACT INTRODUCTION Storiform collagenoma is a rare tumor, which originates from the Storiform collagenoma or sclerotic fibroma is a rare proliferation of fibroblasts that show increased production of type-I benign skin tumor that usually affects young adults collagen. It is usually found in the face, neck and extremities, but and middle-age individuals of both sexes. This tumor is it can also appear in the trunk, scalp and, less frequently, in the slightly predominant in women. Storiform collagenoma oral mucosa and the nail bed. It affects both sexes, with a slight female predominance. It may be solitary or multiple, the latter being appears as a small papule or solid fibrous nodule. an important marker for Cowden syndrome. It presents as a painless, It is well-circumscribed, pink, whitish or skin color, solid nodular tumor that is slow-growing. It must be considered in the painless and of slow-growing. This tumor is often differential diagnosis of other well-circumscribed skin lesions, such as found in face and limbs, but it can also appears in dermatofibroma, pleomorphic fibroma, sclerotic lipoma, fibrolipoma, the chest, scalp and, rarely, in oral mucosa and nail giant cell collagenoma, benign fibrous histiocytoma, intradermal Spitz bed. Storiform collagenoma often appears as single nevus and giant cell angiohistiocytoma. tumor, and the occurrence of multiple tumors is an important indication of Cowden syndrome, which is Keywords: Collagen; Hamartoma; Skin neoplasms; Fibroma; Skin; Case a heritage genodermatosis of autosomal dominant reports condition.(1-4) Storiform collagenoma has as differential diagnosis other well-circumscribed skin tumors such RESUMO as dermatofibroma, pleomorphic fibroma, sclerotic O colagenoma estoriforme é um tumor raro originado a partir da lipoma, fibrolipoma, giant cell collagenoma, benign proliferação de fibroblastos com produção aumentada de colágeno tipo I. -
Benign Tumors and Tumor-Like Lesions of the Vulva
Please do not remove this page Benign Tumors and Tumor-like Lesions of the Vulva Heller, Debra https://scholarship.libraries.rutgers.edu/discovery/delivery/01RUT_INST:ResearchRepository/12643402930004646?l#13643525330004646 Heller, D. (2015). Benign Tumors and Tumor-like Lesions of the Vulva. In Clinical Obstetrics & Gynecology (Vol. 58, Issue 3, pp. 526–535). Rutgers University. https://doi.org/10.7282/T3RN3B2N This work is protected by copyright. You are free to use this resource, with proper attribution, for research and educational purposes. Other uses, such as reproduction or publication, may require the permission of the copyright holder. Downloaded On 2021/09/23 14:56:57 -0400 Heller DS Benign Tumors and Tumor-like lesions of the Vulva Debra S. Heller, MD From the Department of Pathology & Laboratory Medicine, Rutgers-New Jersey Medical School, Newark, NJ Address Correspondence to: Debra S. Heller, MD Dept of Pathology-UH/E158 Rutgers-New Jersey Medical School 185 South Orange Ave Newark, NJ, 07103 Tel 973-972-0751 Fax 973-972-5724 [email protected] Funding: None Disclosures: None 1 Heller DS Abstract: A variety of mass lesions may affect the vulva. These may be non-neoplastic, or represent benign or malignant neoplasms. A review of benign mass lesions and neoplasms of the vulva is presented. Key words: Vulvar neoplasms, vulvar diseases, vulva 2 Heller DS Introduction: A variety of mass lesions may affect the vulva. These may be non-neoplastic, or represent benign or malignant neoplasms. Often an excision is required for both diagnosis and therapy. A review of the more commonly encountered non-neoplastic mass lesions and benign neoplasms of the vulva is presented. -
1 Structure and Function of the Skin
Go Back to the Top To Order, Visit the Purchasing Page for Details 1 Chapter 1 Structure and Function of the Skin The skin is the human body’s its largest organ, covering 1.6 m2 of surface area and accounting for approximate- ly 16% of an adult’s body weight. In direct contact with the outside environment, the skin helps to maintain four essential bodily functions: ① retention of moisture and prevention of permeation or loss of other molecules, ② regulation of body temperature, ③ protection of the body from microbes and harmful external influences, and ④ sensation. To understand cutaneous biology and skin diseases, it is very important to learn the structure and functions of normal human skin. A. Skin surface The skin surface is not smooth, but is laced with multiple net- works of fine grooves called sulci cutis. These can be deep or shallow. The slightly elevated areas that are surrounded by shal- lower areas of sulci cutis are called cristae cutis. Sweat pores fed crista cutis by the sweat glands open to the cristae cutis (Fig. 1.1). The orientation of the sulci cutis, which differs depending on body location, is called the dermal ridge pattern. Fingerprints and sulcus cutis patterns on the palms and soles, which are unique to each person, are formed by the sulci cutis. Elastic fibers also run in specific directions in deeper parts of the skin, with the direction depend- aabcdefg h i j klmnopqr ing on the site. Some skin diseases, such as epidermal nevus, are known to occur along specific lines distributed over the body, the Blaschko lines (Fig. -
A Single Case Report of Granular Cell Tumor of the Tongue Successfully Treated Through 445 Nm Diode Laser
healthcare Case Report A Single Case Report of Granular Cell Tumor of the Tongue Successfully Treated through 445 nm Diode Laser Maria Vittoria Viani 1,*, Luigi Corcione 1, Chiara Di Blasio 2, Ronell Bologna-Molina 3 , Paolo Vescovi 1 and Marco Meleti 1 1 Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy; [email protected] (L.C.); [email protected] (P.V.); [email protected] (M.M.) 2 Private practice, Centro Medico Di Blasio, 43121 Parma; Italy; [email protected] 3 Faculty of Dentistry, University of the Republic, 14600 Montevideo, Uruguay; [email protected] * Correspondence: [email protected] Received: 10 June 2020; Accepted: 11 August 2020; Published: 13 August 2020 Abstract: Oral granular cell tumor (GCT) is a relatively rare, benign lesion that can easily be misdiagnosed. Particularly, the presence of pseudoepitheliomatous hyperplasia might, in some cases, lead to the hypothesis of squamous cell carcinoma. Surgical excision is the treatment of choice. Recurrence has been reported in up to 15% of cases treated with conventional surgery. Here, we reported a case of GCT of the tongue in a young female patient, which was successfully treated through 445 nm diode laser excision. Laser surgery might reduce bleeding and postoperative pain and may be associated with more rapid healing. Particularly, the vaporization effect on remnant tissues could eliminate GCT cells on the surgical bed, thus hypothetically leading to a lower rate of recurrence. In the present case, complete healing occurred in 1 week, and no recurrence was observed after 6 months. Laser surgery also allows the possibility to obtain second intention healing. -
Network Scan Data
CTEP Protocol No: T-99-0090 CC Protocol No: 01-C-0222 Amendment: J Revised: 4/21/09 IRB Approval Date: A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas Coordinating Center: Pediatric Oncology Branch, NCI Principal Investigator: Brigitte Widemann, M.D.* (POB, NCI) NIH Associate Investigators: Frank M. Balis, M.D. (POB, NCI) Beth Fox, M.D. (POB, NCI) Kathy Warren, M.D. (NOB, NCI) Andy Gillespie, R.N. (ND, CC) Eva Dombi, MD (POB, NCI)** Nalini Jayaprakash, (POB, NCI) Diane Cole, (POB, NCI) Seth Steinberg, Ph.D. (BDMB, DCS, NCI) Nicholas Patronas, M.D. (DR, CC)** Maria Tsokos, M.D., (Laboratory of Pathology, NCI)** Pamela Wolters, Ph.D. (HAMB, NCI) Staci Martin, Ph.D. (HAMB, NCI) Jeffrey Solomon, (NIH and Sensor Systems, Inc.) Non-NIH Associate Investigators: Wanda Salzer, M.D. ** Keesler Air Force Base, Biloxi, Mississippi) 81st MDOS/SGOC 301 Fisher Street, Room 1A132 Keesler AFB, MS 39534-2519 Phone: 228-377-6524 E-mail: [email protected] Bruce R. Korf, M.D., Ph.D. ** Chair, Department of Genetics Univeristy of Alabama at Birmingham 1530 3rd Ave. S. Birmingham, AL 35294 Phone: (205)-934-9411, Fax: (205)-934-9488 E-mail: [email protected] David H. Gutmann, M.D., Ph.D. ** Department of Neurology Washington University School of Medicine St. Louis Children’s Hospital Box 8111, 660 S. Euclid Avenue St. Louis, MO 63110 Phone: (314)-632-7149, Fax: (314)-362-9462 E-mail: [email protected] 1 4/21/2009 T-99-0090, 01-C-0222 Arie Perry, M.D. -
Appendix 4 WHO Classification of Soft Tissue Tumours17
S3.02 The histological type and subtype of the tumour must be documented wherever possible. CS3.02a Accepting the limitations of sampling and with the use of diagnostic common sense, tumour type should be assigned according to the WHO system 17, wherever possible. (See Appendix 4 for full list). CS3.02b If precise tumour typing is not possible, generic descriptions to describe the tumour may be useful (eg myxoid, pleomorphic, spindle cell, round cell etc), together with the growth pattern (eg fascicular, sheet-like, storiform etc). (See G3.01). CS3.02c If the reporting pathologist is unfamiliar or lacks confidence with the myriad possible diagnoses, then at this point a decision to send the case away without delay for an expert opinion would be the most sensible option. Referral to the pathologist at the nearest Regional Sarcoma Service would be appropriate in the first instance. Further International Pathology Review may then be obtained by the treating Regional Sarcoma Multidisciplinary Team if required. Adequate review will require submission of full clinical and imaging information as well as histological sections and paraffin block material. Appendix 4 WHO classification of soft tissue tumours17 ADIPOCYTIC TUMOURS Benign Lipoma 8850/0* Lipomatosis 8850/0 Lipomatosis of nerve 8850/0 Lipoblastoma / Lipoblastomatosis 8881/0 Angiolipoma 8861/0 Myolipoma 8890/0 Chondroid lipoma 8862/0 Extrarenal angiomyolipoma 8860/0 Extra-adrenal myelolipoma 8870/0 Spindle cell/ 8857/0 Pleomorphic lipoma 8854/0 Hibernoma 8880/0 Intermediate (locally -
Acral Manifestations of Soft Tissue Tumors Kristen M
Clinics in Dermatology (2017) 35,85–98 Acral manifestations of soft tissue tumors Kristen M. Paral, MD, Vesna Petronic-Rosic, MD, MSc⁎ Section of Dermatology, University of Chicago Pritzker School of Medicine, Chicago, IL Abstract This group of biologically diverse entities is united by topographic localization to the hands and feet. Categorizing tumors by body site narrows the differential into a short list of possibilities that can facil- itate accurate and rapid diagnosis. The goal of this review is to provide a practical approach to soft tissue tumors of acral locations for clinicians, pathologists, and researchers alike. What ensues in the following text is that tight coupling of the clinical picture and histopathologic findings should produce the correct diagno- sis, or at least an abbreviated differential. The salient clinicopathologic, immunohistochemical, and molec- ular features are presented alongside current treatment recommendations for each entity. © 2017 Elsevier Inc. All rights reserved. Introduction actin (SMA) and are deemed “myofibroblasts.”1 The tumors under this heading express combinations of CD34, FXIIIa, fi The entities presented herein are categorized on the basis of and SMA. The synthesis of collagen by broblasts translates fi fi morphogenesis (where possible) and by biologic potential as to a brous consistency that clinically imparts a rm texture benign, intermediate, and malignant neoplasms. on palpation, and, macroscopically, a gray-white or white-tan cut surface. The entities discussed next have no metastatic po- tential; that is, simple excision is adequate. Fibrous and related tissues: Benign lesions Fibroma of tendon sheath fi fl The ontogenetic classi cation of benign lesions re ects appar- Also known as tenosynovial fibroma, compared with other fi fi fi ent broblastic or broblast-like morphogenesis. -
Dermoscopy of Aplasia Cutis Congenita: a Case Report and Review of the Literature
Dermatology Practical & Conceptual Dermoscopy of Aplasia Cutis Congenita: A Case Report and Review of the Literature Rasna Neelam1, Mio Nakamura2, Trilokraj Tejasvi2 1 University of Michigan Medical School, Ann Arbor, MI, USA 2 Department of Dermatology, University of Michigan, Ann Arbor, MI, USA Key words: aplasia cutis congenita, alopecia, dermoscopy, trichoscopy Citation: Neelam R, Nakamura M, Tejasvi T. Dermoscopy of aplasia cutis congenita: a case report and review of the literature. Dermatol Pract Concept. 2021;11(1):e2021154. DOI: https://doi.org/10.5826/dpc.1101a154 Accepted: September 28, 2020; Published: January 29, 2021 Copyright: ©2021 Neelam et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License BY-NC-4.0, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: None. Competing interests: The authors have no conflicts of interest to disclose. Authorship: All authors have contributed significantly to this publication. Corresponding author: Trilokraj Tejasvi, MD, Department of Dermatology, University of Michigan, 1910 Taubman Center, 1500 E. Medical Center Dr, Ann Arbor, MI 48109, USA Email: [email protected] Introduction throbbing, and point tenderness in one of the patches of alo- pecia. The alopecic patch had been present on the right pari- Aplasia cutis congenita (ACC) is a rare heterogeneous con- etal-occipital scalp since birth and has been stable in size and genital disorder characterized by focal or widespread absence appearance for years. Three other round patches of alopecia of the skin. had also been present since birth and remained asymptomatic. -
Dermatofibrosarcoma Protuberans and Dermatofibroma: Dermal Dendrocytomas? a Ultrastructural Study
Dermatofibrosarcoma Protuberans and Dermatofibroma: Dermal Dendrocytomas? A Ultrastructural Study Hugo Dominguez-Malagon, M.D., Ana Maria Cano-Valdez, M.D. Department of Pathology, Instituto Nacional de Cancerología, Mexico. ABSTRACT population of plump spindled cells devoid of cell processes, these cells contained intracytoplasmic lipid droplets and rare Dermatofibroma (DF) and Dermatofibrosarcoma subplasmalemmal densities but lacked MVB. Protuberans (DFSP) are dermal tumors whose histogenesis has not been well defined to date. The differential diagnosis in most With the ultrastructural characteristics and the constant cases is established in routine H/E sections and may be confirmed expression of CD34 in DFSP, a probable origin in dermal by immunohistochemistry; however there are atypical variants dendrocytes is postulated. The histogenesis of DF remains of DF with less clear histological differences and non-conclusive obscure. immunohistochemical results. In such cases electron microscopy studies may be useful to establish the diagnosis. INTRODUCTION In the present paper the ultrastructural characteristics of 38 The histogenesis or differentiation of cases of DFSP and 10 cases of DF are described in detail, the Dermatofibrosarcoma Protuberans (DFSP) and objective was to identify some features potentially useful for Dermatofibroma (DF) is controversial in the literature. For differential diagnosis, and to identify the possible histogenesis of DFSP diverse origins such as fibroblastic,1 fibro-histiocytic2 both neoplasms. Schwannian,3 myofibroblastic,4 perineurial,5,6 and endoneurial (7) have been postulated. DFSP in all cases was formed by stellate or spindled cells with long, slender, ramified cell processes joined by primitive junctions, Regarding DF, most authors are in agreement of a subplasmalemmal densities were frequently seen in the processes. -
Depo-Provera
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR ® DEPO-PROVERA medroxyprogesterone acetate injectable suspension, USP Sterile Aqueous Suspension 50 mg/mL and 150 mg/mL Progestogen Pfizer Canada Inc. Date of Revision: 17,300 Trans-Canada Highway February 13, 2018 Kirkland, Quebec H9J 2M5 Submission Control No: 210121 ® Pharmacia & Upjohn Company LLC Pfizer Canada Inc., Licensee © Pfizer Canada Inc., 2018 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION......................................................... 3 SUMMARY PRODUCT INFORMATION ........................................................................ 3 INDICATIONS AND CLINICAL USE .............................................................................. 3 CONTRAINDICATIONS ................................................................................................... 4 WARNINGS AND PRECAUTIONS: ................................................................................ 5 ADVERSE REACTIONS ................................................................................................. 18 DRUG INTERACTIONS .................................................................................................. 27 DOSAGE AND ADMINISTRATION .............................................................................. 28 OVERDOSAGE ................................................................................................................ 30 ACTION AND CLINICAL PHARMACOLOGY ............................................................ 30 STORAGE AND